{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:47:27Z","timestamp":1773370047702,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","doi-asserted-by":"crossref","award":["2015CB554300"],"award-info":[{"award-number":["2015CB554300"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","doi-asserted-by":"crossref","award":["2016YFC1200400"],"award-info":[{"award-number":["2016YFC1200400"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.antiviral.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:20:32Z","timestamp":1523362832000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system"],"prefix":"10.1016","volume":"154","author":[{"given":"Wang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawad","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.04.007_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/spid.2002.125859","article-title":"Hepatitis A vaccine","volume":"13","author":"Bell","year":"2002","journal-title":"Seminars Pediatr. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.007_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3851\/IMP2425","article-title":"HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents","volume":"17","author":"Calle Serrano","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.04.007_bib3","first-page":"30","article-title":"CDC provides advice on recent hepatitis A outbreaks","volume":"67","author":"Campos-Outcalt","year":"2018","journal-title":"J. Fam. Pract."},{"key":"10.1016\/j.antiviral.2018.04.007_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","article-title":"Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin","volume":"150","author":"Dao Thi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.04.007_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.antiviral.2013.03.016","article-title":"Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication","volume":"98","author":"Debing","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.007_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/med.21292","article-title":"Molecular biology and inhibitors of hepatitis A virus","volume":"34","author":"Debing","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2018.04.007_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jmv.1890300210","article-title":"Persistence of hepatitis A virus in fulminant hepatitis and after liver transplantation","volume":"30","author":"Fagan","year":"1990","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.04.007_bib8","series-title":"Hepatitis B and C Treatments","author":"FDA","year":"2017"},{"key":"10.1016\/j.antiviral.2018.04.007_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature12029","article-title":"A pathogenic picornavirus acquires an envelope by hijacking cellular membranes","volume":"496","author":"Feng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.04.007_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.vaccine.2009.10.136","article-title":"Hepatitis A and E: update on prevention and epidemiology","volume":"28","author":"FitzSimons","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.04.007_bib11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/ajt.12209","article-title":"Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C","volume":"13","author":"Fontana","year":"2013","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.antiviral.2018.04.007_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01998-16","article-title":"Biliary secretion of quasi-enveloped human hepatitis a virus","volume":"7","author":"Hirai-Yuki","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2018.04.007_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/COH.0000000000000007","article-title":"Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors","volume":"8","author":"Hurwitz","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.antiviral.2018.04.007_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1096-9071(199612)50:4<322::AID-JMV7>3.0.CO;2-A","article-title":"Chronic hepatitis A with persistent viral replication","volume":"50","author":"Inoue","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.04.007_bib15","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"Hepatitis A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.04.007_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt.1604","article-title":"Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system","volume":"28","author":"Jones","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2018.04.007_bib18","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1002\/hep.21052","article-title":"Hepatitis A virus: from discovery to vaccines","volume":"43","author":"Martin","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.04.007_bib19","article-title":"Protein composition of the hepatitis A virus quasi-envelope","volume":"7","author":"McKnight","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2018.04.007_bib20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.04.007_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.antiviral.2017.09.004","article-title":"Cell-line dependent antiviral activity of sofosbuvir against Zika virus","volume":"146","author":"Mumtaz","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.04.007_bib22","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"Murakami","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.04.007_bib23","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1016\/j.transproceed.2010.09.151","article-title":"Intractable recurrent hepatitis A virus infection requiring repeated liver transplantation: a case report","volume":"42","author":"Park","year":"2010","journal-title":"Transpl. Proc."},{"issue":"19","key":"10.1016\/j.antiviral.2018.04.007_bib24","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.04.007_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1756283X13515825","article-title":"Sofosbuvir, a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential","volume":"7","author":"Stedman","year":"2014","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.antiviral.2018.04.007_bib26","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3748\/wjg.v10.i17.2571","article-title":"A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor","volume":"10","author":"Sun","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.antiviral.2018.04.007_bib27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/infdis\/168.3.592","article-title":"Attenuation phenotype of a cell culture-adapted variant of hepatitis A virus (HM175\/p16) in susceptible New World owl monkeys","volume":"168","author":"Taylor","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.007_bib28","series-title":"World Health Organization. Global Hepatitis Report 2017","author":"WHO","year":"2017"},{"key":"10.1016\/j.antiviral.2018.04.007_bib29","series-title":"World Health Organization. Hepatitis a Fact Sheet","author":"WHO","year":"2017"},{"key":"10.1016\/j.antiviral.2018.04.007_bib30","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1073\/pnas.0611506104","article-title":"Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor","volume":"104","author":"Yang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.04.007_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01353-16","article-title":"Neglected but important role of apolipoprotein E exchange in hepatitis C virus infection","author":"Yang","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.007_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0140-6736(94)91132-0","article-title":"Interferon for hepatitis A","volume":"343","author":"Yoshiba","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.antiviral.2018.04.007_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1006\/viro.1995.1526","article-title":"An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect","volume":"212","author":"Zhang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.04.007_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01720-16","article-title":"Visualizing the essential role of complete virion assembly machinery in efficient hepatitis C virus cell-to-cell transmission by a viral infection-activated split-intein-mediated reporter system","volume":"91","author":"Zhao","year":"2017","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:21Z","timestamp":1759062441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218300809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"alternative-id":["S0166354218300809"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}